维普期刊资源整合服务平台（V6.5）

102篇 您的检索式：作者名="WILDING JP"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Neuropeptides and appetite control显示文摘	Wilding JP	2002	Dia-bet Med2002，19，8：	1
2	Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately con- trolled with metformin and sulphonylurea: a randomized trial显示文摘	Wilding JP Charpentier G Hollander P	2013	Int J Clin Pract2013，67，12：	1
3	Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Feder- ation Taskforce on Epidemiology and Prevention 显示文摘	Shaw JE Punjabi NM Wilding JP	2008	Diabetes Res Clin Pract2008，81，1：	1
4	Platelet rich plasma on calcium phosphate granules promotes metaphyseal bone healing in mini pigs显示文摘	Jungbluth P Wild M Grassmann JP	2010	J Orthop Res2010，28，11：	1
5	Sleep-disordered breathing and type 2 diabetes:a report from the International diabetes federation taskforce on epidemiology and prevention显示文摘	Shaw JE Punjabi NM Wilding JP	2008	Diabetes Res Clin Pract2008，81，1：	1
6	obesity and type 2 diabetes in the elderly 显示文摘	Dewan S Wilding JP	2003	Gerontology2003，49，3：	1
7	Gut peptides and the regulation of appetite显示文摘	Huda MS Wilding JP Pinkney JH	2006	Obes Rev2006，7，2：	1
8	Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years显示文摘	Wilding JP Woo V Rohwedder K	2014	Diabetes Obes Metab2014，16，2：	1
9	A study of dapagliflozin in patients with type2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment 显示文摘	Wilding JP Norwood P	2009	Diabetes Care2009，9，：	1
10	Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin : a randomizedtrial显示文摘	Wilding JP Woo V	2012	Ann Intern Med2012，6，：	1
11	Sodium glucose cotransporter 2 inhibitors as a new treatment for diabetes mellitus 显示文摘	Nair S Wilding JP	2010	J Clin Endocr Metab2010，5，1：	1
12	Effects of olanzapine in male rats:enhanced adiposity in the absence of hyperphagia,weight gain or metabolic abnormalities显示文摘	Cooper GD Pickavance LC Wilding JP		0，，04：	1
13	Sequential axi- tinib (AG-013736) therapy of patients (pts) with metastatie clear cell renal cell eaneer (RCC) refractory to sunitinib and sorafenib, eytokines and sorafenib, or sorafenib alone 显示文摘	DUTCHER JP WILDING G HUDES GR	2008	J Clin Oneol2008，26，15：	1
14	Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years 显示文摘	Wilding JP Woo V	2013	Diabetes Obes Metab2013，16，2：	1
15	A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers:applicability of a novel insulin-independent treatment 显示文摘	Wilding JP Norwood P T'Joen C	2009	Diabetes Care2009，32，9：	1
16	Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus re- ceiving high doses of insulin 显示文摘	Wilding JP Woo V Soler NG	2013	Dtsch Med Wochenschr2013，1381，：	1
17	Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes显示文摘	Boyle LD Wilding JP	2013	Expert Opin Emerg Drugs2013，18，3：	1
18	Obesity and diabetes显示文摘	Leong KS Wilding JP	1999	Baillieres Clin Endocrinol Metab1999，13，2：	1
19	Long-term efficacy of dapagliflo- zin in patients with type 2 diabetes mellitus receiving high doses of in- sulih显示文摘	Wilding JP Woo V Soler NG	2013	Dtsch Med Wochenschr2013，138，1：	1
20	Efficaey and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with mefformin and sulphonylurea: a randomised trial显示文摘	Wilding JP Charpentier G	2013	Int J Clin Praet2013，67，12：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示